BlackRock Health Sciences Trust II (NYSE: BMEZ) — Perfil da empresa, notícias e dados financeiros
BlackRock Health Sciences Trust II invests in global health sciences companies, focusing on income and capital appreciation.
BlackRock Health Sciences Trust II
BlackRock Health Sciences Trust II (NYSE:BMEZ) is focused on investing in the dynamic and rapidly evolving healthcare and sciences sector. This investment trust seeks to provide shareholders with high income, capital appreciation, and growth by primarily investing in equity securities of companies worldwide that are engaged in the health sciences and related industries. With a strategic approach to selecting investments in pharmaceuticals, biotechnology, healthcare equipment, and technology, BlackRock Health Sciences Trust II aims to leverage the ongoing advancements and innovations in the health sector to benefit its investors. Through careful market analysis and a diversified portfolio, the trust strives to tap into the potential of the health sciences industry, addressing both current and future global health challenges.
Resumo
Operações
Produtos e/ou serviços de BlackRock Health Sciences Trust II
- Investment in pharmaceutical advancements, focusing on developing cutting-edge medications.
- Biotechnology research funding, supporting innovation in genetic and molecular therapies.
- Healthcare technology upgrades, enhancing patient care through advanced medical devices.
- Medical services expansion, investing in facilities and staff to improve patient access.
- Health science education programs, providing scholarships and grants for future healthcare professionals.
- Wellness and prevention initiatives, aiming to improve public health outcomes through awareness and early detection.
equipe executiva do BlackRock Health Sciences Trust II
- Xiang LiuPortfolio Manager
Histórico de dividendos
Dividendos por ação pagos pela BlackRock Health Sciences Trust II, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2026(até o momento) | — | — | — | $1.3200 |
| FY2025 | — | — | — | $1.8700 |
| FY2024 | — | — | — | $1.6900 |
| FY2023 | — | — | — | $1.5830 |
| FY2022 | — | — | — | $1.7400 |
Principais indicadores financeiros
Resultados divulgados pela BlackRock Health Sciences Trust II, em USD.
- Cap. de mercado
- 1,1 bi
- Receita (TTM)
- 0
- P/L
- 5.1
- LPA (diluído, TTM)
- 3.4
- Dividend yield
- 0.0%
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 24,1 mi | 927,2 mil | 23,5 mi | |
| 8,2 mi | 8,5 mi | 20 mi | |
| -26 mi | 1,5 mi | -26,5 mi | |
| 59,7 mi | 53,9 mil | 59,1 mi |